Clinical Trials for Chengdu Kanghong Pharmaceutical Group

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Chengdu Kanghong Pharmaceutical Group

Clinical Trials (5)

NCT07101120
A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents With Major Depressive Disorder
PHASE2Not yet recruiting
120 participants
Started: Aug 31, 2025 · Completed: Apr 30, 2026
1 condition1 sponsor0 locations
NCT07096791
A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression
PHASE2Not yet recruiting
72 participants
Started: Jul 31, 2025 · Completed: Apr 30, 2027
1 condition1 sponsor0 locations
NCT07044960
A Phase 1 Study of KHN702 Tablets in Healthy Subjects
PHASE1Not yet recruiting
84 participants
Started: Jun 21, 2025 · Completed: Apr 1, 2026
1 condition1 sponsor0 locations
NCT06589817
A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia
PHASE3Not yet recruiting
376 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT06393803
Phase 1 Study of KH607 Tablets
PHASE1Recruiting
88 participants
Started: Oct 21, 2023 · Completed: Oct 30, 2024
1 condition1 sponsor1 location